Bart J. Dunn
Corporate Officer/Principal bei COLLEGIUM PHARMACEUTICAL, INC.
Profil
Bart J.
Dunn is currently the Executive VP-Strategy & Corporate Development at Collegium Pharmaceutical, Inc. He previously worked as the Director-Business Development at Pfizer Inc. From 2006 to 2011, he held the position of Vice President-Business Development at Inspire Pharmaceuticals, Inc. He also served as the Vice President-Strategy & Corporate Development at Patheon, Inc. and as the Vice President-Corporate Development & Licensing at NuPathe, Inc. Prior to that, he was the Senior Vice President-Corporate Development at Vivelix Pharmaceuticalsc Corp.
Mr. Dunn completed his undergraduate degree at Pace University and holds an MBA from St. Joseph's University.
Aktive Positionen von Bart J. Dunn
| Unternehmen | Position | Beginn |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | 01.08.2019 |
Ehemalige bekannte Positionen von Bart J. Dunn
| Unternehmen | Position | Ende |
|---|---|---|
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Corporate Officer/Principal | - |
| PATHEON, INC. | Corporate Officer/Principal | - |
| Vivelix Pharmaceuticalsc Corp. | Corporate Officer/Principal | - |
| NUPATHE INC | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Ausbildung von Bart J. Dunn
| Pace University | Undergraduate Degree |
| St. Joseph's University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
| Vivelix Pharmaceuticalsc Corp. |
